Cure My Disease

Don't miss your cure!

 Log in / Sign up

Early trial tests promising new combo for Tough-to-Treat lymphoma

NCT ID NCT05685173

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study testing the safety and side effects of a new two-drug combination (REGN5837 plus odronextamab) for people with aggressive B-cell non-Hodgkin lymphoma that has come back or stopped responding to at least two prior treatments. The main goal is to find a safe dose for future testing. Researchers will also check if the treatment helps shrink the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-CELL NON-HODGKINS LYMPHOMA (B-NHL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam University Medical Centre, location AMC

    RECRUITING

    Amsterdam, 1100AZ, Netherlands

  • CHU de Bordeaux

    RECRUITING

    Talence, Nouvelle-Aquitaine, 33404, France

  • City of Hope

    RECRUITING

    Duarte, California, 91010, United States

  • Erasmus Medical Center Rotterdam

    RECRUITING

    Rotterdam, South Holland, 3015, Netherlands

  • Gustave Roussy

    RECRUITING

    Villejuif, Île-de-France Region, 94800, France

  • Harvard Medical School - Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Hopital Saint Louis

    RECRUITING

    Paris, 75010, France

  • Hospital Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • NYU Langone Health Perlmutter Cancer Center

    RECRUITING

    New York, New York, 10016, United States

  • Norton Cancer Institute

    RECRUITING

    Louisville, Kentucky, 40207, United States

  • Royal Cornwall Hospitals NHS Trust

    RECRUITING

    Truro, Cornwall, TR1 3LJ, United Kingdom

  • Rutgers Cancer Institute of New Jersey

    RECRUITING

    New Brunswick, New Jersey, 08901, United States

  • Southampton General Hospital

    RECRUITING

    Southampton, Hampshire, SO16 6YD, United Kingdom

  • The Christie NHS Foundation Trust

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • UT Southwestern

    RECRUITING

    Dallas, Texas, 75390, United States

  • University Hospital and Research Institute

    RECRUITING

    Madrid, 28041, Spain

  • University of California Los Angeles (UCLA) Medical Center

    RECRUITING

    Santa Monica, California, 90404, United States

  • Western General Hospital

    RECRUITING

    Edinburgh, Scotland, EH4 2XU, United Kingdom

Conditions

Explore the condition pages connected to this study.

B-CELL NON-HODGKINS LYMPHOMA (B-NHL)